Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Dong Lin
Affiliation
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
ORCID
Career Start Year
1996
Papers
262
H Index
38
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36895949
Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats.
Front Pharmacol
2023
37160927
RNU12 inhibits gastric cancer progression via sponging miR-575 and targeting BLID.
Sci Rep
2023
37025467
Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta-analysis.
BJUI Compass
2023
37085377
Cost-effectiveness and Value-based Pricing of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Low HER2 Expression.
Clin Breast Cancer
2023
37452083
Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.
Cancer Gene Ther
2023
37347559
Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth.
J Clin Invest
2023
37306960
Pleiotropic Association of CACNA1C Variants With Neuropsychiatric Disorders.
Schizophr Bull
2023
37096505
[Clinical Analysis of <i>SET-NUP214</i> Fusion Gene Positive Patients with Acute Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
2023
36996867
Disease burden of prostate cancer from 2014 to 2019 in the United States: estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey.
Epidemiol Health
2023
36890161
A significant, functional and replicable risk KTN1 variant block for schizophrenia.
Sci Rep
2023
36751862
Clinical features of patients with acute myeloid leukaemia and the NUP98::NSD1 fusion gene.
Int J Lab Hematol
2023
36609385
Male-specific, replicable and functional roles of genetic variants and cerebral gray matter volumes in ADHD: a gene-wide association study across KTN1 and a region-wide functional validation across brain.
Child Adolesc Psychiatry Ment Health
2023
34767925
Patient-derived xenograft models of neuroendocrine prostate cancer.
Cancer Lett
2022
35775251
[Multicenter retrospective study of 38 cases with fumarate hydratase deficiency uterine leiomyoma].
Zhonghua Fu Chan Ke Za Zhi
2022
35680626
[Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study].
Zhonghua Xue Ye Xue Za Zhi
2022
35680595
[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].
Zhonghua Xue Ye Xue Za Zhi
2022
35544458
A short report of novel <i>RARG-HNRNPM fusion</i> gene in resembling acute promyelocytic leukemia.
Hematology
2022
35399543
The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia.
Blood Sci
2022
35535310
Upregulation of PNCK Promotes Metastasis and Angiogenesis via Activating NF-<i>κ</i>B/VEGF Pathway in Nasopharyngeal Carcinoma.
J Oncol
2022
35570146
[Comparative Study of PD-L1 Expression in Different Sites of â¿©Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi
2022
35627232
Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis.
Genes (Basel)
2022
35563856
Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.
Cells
2022
35685655
The Evaluation Value of Diffusion-Weighted Imaging for Brain Injury in Patients after Deep Hypothermic Circulatory Arrest.
Contrast Media Mol Imaging
2022
35591654
Phase Prediction of High-Entropy Alloys by Integrating Criterion and Machine Learning Recommendation Method.
Materials (Basel)
2022
35654767
Sex-different interrelationships of rs945270, cerebral gray matter volumes, and attention deficit hyperactivity disorder: a region-wide study across brain.
Transl Psychiatry
2022
36439099
CD8<sup>+</sup> T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types.
Front Immunol
2022
36709173
[Analysis of the efficacy of azacitidine combined with homoharringtonine and cytarabine in induction and salvage therapy of acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
2022
36210441
Prognostic value of long-term antidiabetic and antihypertensive therapy in postoperative gastric cancer patients: the FIESTA study.
BMC Gastroenterol
2022
36199105
Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3).
Diagn Pathol
2022
36161433
Early-salvage therapy with venetoclax-based regimens for induction failure and poor early response acute lymphoblastic leukaemia: A retrospective case series of 13 patients.
Br J Haematol
2022
35274287
The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm).
Br J Haematol
2022
35082166
Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.
Mol Cancer Res
2022
35340014
Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review.
Acta Haematol
2022
33038264
GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.
Int J Cancer
2021
33793068
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms.
Mol Oncol
2021
33568749
ZRSR2 overexpression is a frequent and early event in castration-resistant prostate cancer development.
Prostate Cancer Prostatic Dis
2021
33565239
EXT1 methylation promotes proliferation and migration and predicts the clinical outcome of non-small cell lung carcinoma via WNT signalling pathway.
J Cell Mol Med
2021
33665079
Auer rods in mixed phenotype acute leukemia, T/myeloid: A report of three cases.
Leuk Res Rep
2021
33750801
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
Nat Commun
2021
33858040
[Dasatinib combined with multi-agent chemotherapy regimen in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective study from a single center].
Zhonghua Xue Ye Xue Za Zhi
2021
33524443
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1.
Exp Hematol
2021
34917553
Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis.
J Hepatocell Carcinoma
2021
34496499
[Clinicopathological and molecular genetic study of 10 cases of tracheal glomus tumors].
Zhonghua Bing Li Xue Za Zhi
2021
34722282
SNHG8 Promotes the Progression of Epstein-Barr Virus-Associated Gastric Cancer <i>via</i> Sponging miR-512-5p and Targeting TRIM28.
Front Oncol
2021
34805186
Competitive Endogenous RNA Landscape in Epstein-Barr Virus Associated Nasopharyngeal Carcinoma.
Front Cell Dev Biol
2021
34508169
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions.
NPJ Precis Oncol
2021
34530914
Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified.
Exp Hematol Oncol
2021
33940066
Novel dibenzofuran and biphenyl phytoalexins from Sorbus pohuashanensis suspension cell and their antimicrobial activities.
Fitoterapia
2021
33960594
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.
Cancer Sci
2021
34150641
Gene Deletions and Prognostic Values in B-Linage Acute Lymphoblastic Leukemia.
Front Oncol
2021
1 - 50 of 262
Column Actions
Search
Recommended Authors
Jiayu Liang
institute of urology
Career Start Year
2016
Number of shared co-authors
1
Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year
2015
Number of shared co-authors
1
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
2013
Number of shared co-authors
11
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year
2012
Number of shared co-authors
0
Zhixin Qiu
UPMC Hillman Cancer Center
Career Start Year
2012
Number of shared co-authors
0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year
2010
Number of shared co-authors
2
Lu Ji
West China Hospital, Sichuan University
Career Start Year
2010
Number of shared co-authors
0
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year
2008
Number of shared co-authors
0
Liang Cao
National Cancer Institute, National Institutes of Health
Career Start Year
2008
Number of shared co-authors
0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year
2007
Number of shared co-authors
2
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year
2006
Number of shared co-authors
1
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year
2005
Number of shared co-authors
0
Li Liu
College of Big Data & Software Engineering, Chongqing University
Career Start Year
2005
Number of shared co-authors
1
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year
2004
Number of shared co-authors
12
Ji Zhang
Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year
2004
Number of shared co-authors
0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year
2003
Number of shared co-authors
0
Wenhua Liang
The First People's Hospital of Zhaoqing
Career Start Year
2003
Number of shared co-authors
0
Xiaojie Bian
Fudan University Shanghai Cancer Center
Career Start Year
2003
Number of shared co-authors
8
Xin Yang
Peking University Cancer Hospital & Institute
Career Start Year
2002
Number of shared co-authors
1
Yongwei Yu
Changhai Hospital
Career Start Year
2001
Number of shared co-authors
13
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year
2001
Number of shared co-authors
2
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
2
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year
2000
Number of shared co-authors
1
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year
1998
Number of shared co-authors
1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1997
Number of shared co-authors
7
Nan Wu
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
Career Start Year
1997
Number of shared co-authors
0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
0
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year
1995
Number of shared co-authors
0
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year
1993
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Yuzhuo Wang
University of British Columbia
Co-authored papers
58
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers
36
Colin C Collins
University of British Columbia
Co-authored papers
35
Martin E Gleave
University of British Columbia
Co-authored papers
26
Ladan Fazli
University of British Columbia
Co-authored papers
15
Xinpei Ci
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
13
Anne Haegert
University of British Columbia
Co-authored papers
12
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers
10
Alexander W Wyatt
University of British Columbia
Co-authored papers
10
Amina Zoubeidi
University of British Columbia
Co-authored papers
8
Robert H Bell
University of British Columbia
Co-authored papers
7
Sonal Brahmbhatt
University of British Columbia
Co-authored papers
6
Enhua Wang
The First Hospital and College of Basic Medical Sciences, China Medical University
Co-authored papers
6
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers
6
Stanislav V Volik
University of British Columbia
Co-authored papers
6
Wan L Lam
British Columbia Cancer Research Institute
Co-authored papers
5
Varune R Ramnarine
University of British Columbia
Co-authored papers
4
Kan Jiang
Co-authored papers
4
Mark A Rubin
University of Bern
Co-authored papers
4
Akira Watahiki
Co-authored papers
3
Shawn Anderson
University of British Columbia
Co-authored papers
3
Andrew McPherson
Memorial Sloan Kettering Cancer Center
Co-authored papers
3
Elai Davicioni
Veracyte Inc.
Co-authored papers
3
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers
3
Robert Shukin
University of British Columbia
Co-authored papers
3
Raunak Shrestha
University of California San Francisco
Co-authored papers
2
Wuming Gong
Lillehei Heart Institute, University of Minnesota
Co-authored papers
2
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers
2
Anna Lapuk
Contextual Genomics Inc.
Co-authored papers
2
1 - 30